Flarex Related Published Studies
Well-designed clinical trials related to Flarex (Fluorometholone Ophthalmic)
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2009.08]
Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis. [2009.06]
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2008.07.08]
Well-designed clinical trials possibly related to Flarex (Fluorometholone Ophthalmic)
Mitomycin-C in hyperopic photorefractive keratectomy. [2009.04]
Mitomycin C in photorefractive keratectomy: effect on epithelialization and predictability. [2008.04]
Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. [2005.02]
Other research related to Flarex (Fluorometholone Ophthalmic)
Preclinical investigation of fluorometholone acetate as a potential new adjuvant during vitreous surgery. [2007.07]
Other possibly related research studies
Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. [2006.10]
Haze after photorefractive keratectomy caused by iatrogenic lagophthalmos. [2006.08]
Disappearance of honeycomb opacity of Thiel-Behnke corneal dystrophy after Thygeson superficial punctate keratitis. [2005.11]
Experimental study of an automated system for the delivery of eyedrops using a microinfusion pump. [2005.03]
Isolated large limbal nodule as the presenting feature of vernal keratoconjunctivitis. [2007.01]
Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model. [2007.01]
Multifocal lamellar keratitis following laser in situ keratomileusis. [2007.01]
Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. [2007.02]
Diagnosis and management of Thygeson's superficial punctate keratitis. [2007.07]
The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. [2007.12]
Infectious crystalline keratopathy caused by Serratia marcescens. [2007.09]
Aggravated dry eye after laser in situ keratomileusis in patients with Sjogren syndrome. [2008.01]
Diagnosis of steroid-induced glaucoma after photorefractive keratectomy. [2008.04]
Bacterial keratitis after nonpenetrating glaucoma surgery. [2008.04]
Treatment of recurrent corneal erosion syndrome using the combination of oral doxycycline and topical corticosteroid. [2008.01]
Posttraumatic Stenotrophomonas maltophilia infectious scleritis. [2008.02]
Juvenile xanthogranuloma of the corneal limbus: report of two cases and review of the literature. [2008.07]
Effect of nepafenac sodium 0.1% on delayed corneal epithelial healing and haze after photorefractive keratectomy: retrospective comparative study. [2008.09]
Delayed-onset Actinomyces keratitis after laser in situ keratomileusis. [2008.08]
Short-term effect of topical brinzolamide on human central corneal thickness. [2008.05]
[Post-traumatic striate melanokeratosis in a Caucasian woman] [2009.04]
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye. [2009.04]
The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy. [2009.06]
|
